SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Aerie Pharmaceuticals, Inc. Announces Positive Phase 2a Clinical Results for a Fixed Combination of its Rho Kinase Inhibitor, AR-12286, With Travoprost for the Treatment of Glaucoma
Your Message